Bank of Montreal’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.1K Sell
15,495
-10,606
-41% -$22K ﹤0.01% 2919
2025
Q1
$57.4K Buy
+26,101
New +$57.4K ﹤0.01% 2765
2024
Q4
Sell
-25,194
Closed -$50.1K 3335
2024
Q3
$50.1K Buy
+25,194
New +$50.1K ﹤0.01% 3079
2022
Q3
Sell
-56,680
Closed -$192 3624
2022
Q2
$192 Sell
56,680
-43,920
-44% -$149 ﹤0.01% 2876
2022
Q1
$574K Sell
100,600
-61,530
-38% -$351K ﹤0.01% 2301
2021
Q4
$1.51M Sell
162,130
-2,040
-1% -$19K ﹤0.01% 1685
2021
Q3
$1.88M Sell
164,170
-185,939
-53% -$2.13M ﹤0.01% 1952
2021
Q2
$5.56M Buy
350,109
+347,025
+11,252% +$5.51M ﹤0.01% 1461
2021
Q1
$53K Sell
3,084
-11,094
-78% -$191K ﹤0.01% 3280
2020
Q4
$274K Buy
14,178
+8,207
+137% +$159K ﹤0.01% 2608
2020
Q3
$87K Sell
5,971
-3,129
-34% -$45.6K ﹤0.01% 2770
2020
Q2
$142K Buy
9,100
+7,063
+347% +$110K ﹤0.01% 2556
2020
Q1
$24K Sell
2,037
-12,784
-86% -$151K ﹤0.01% 2877
2019
Q4
$347K Sell
14,821
-15,758
-52% -$369K ﹤0.01% 2408
2019
Q3
$566K Buy
30,579
+22,379
+273% +$414K ﹤0.01% 1963
2019
Q2
$153K Buy
8,200
+5,815
+244% +$108K ﹤0.01% 2646
2019
Q1
$59K Sell
2,385
-48,647
-95% -$1.2M ﹤0.01% 2881
2018
Q4
$1.32M Buy
51,032
+46,384
+998% +$1.2M ﹤0.01% 1583
2018
Q3
$147K Sell
4,648
-580
-11% -$18.3K ﹤0.01% 2632
2018
Q2
$203K Buy
5,228
+527
+11% +$20.5K ﹤0.01% 2463
2018
Q1
$130K Buy
4,701
+750
+19% +$20.7K ﹤0.01% 2619
2017
Q4
$71K Sell
3,951
-149
-4% -$2.68K ﹤0.01% 2835
2017
Q3
$66K Buy
4,100
+704
+21% +$11.3K ﹤0.01% 2868
2017
Q2
$47K Buy
3,396
+500
+17% +$6.92K ﹤0.01% 2945
2017
Q1
$43K Sell
2,896
-7,466
-72% -$111K ﹤0.01% 2882
2016
Q4
$160K Sell
10,362
-1,020
-9% -$15.8K ﹤0.01% 2334
2016
Q3
$196K Buy
11,382
+10,973
+2,683% +$189K ﹤0.01% 2245
2016
Q2
$7K Hold
409
﹤0.01% 3378
2016
Q1
$8K Sell
409
-112,311
-100% -$2.2M ﹤0.01% 3409
2015
Q4
$3.01M Buy
+112,720
New +$3.01M ﹤0.01% 1150